For writers in the early modern period, thinking about royal favorites inevitably meant thinking about the uneasy intersection of the personal and the public in a political system traditionally organized around patronage and intimacy. Depictions of favoritism - in a variety of texts including plays, poems, libels, and pamphlets - explore the most fundamental ideological questions concerning personal monarchy and the early modern public sphere, questions about the nature and limits of prerogative and about the enfranchisement or otherwise of subjects. In this study, Curtis Perry examines the ideological underpinnings of the heated controversies surrounding powerful royal favorites and the idea of favoritism in the late Elizabethan and early Stuart period. Perry argues that the discourse of corrupt favoritism is this period's most important unofficial vehicle for exploring constitutional unease concerning the nature and limits of personal monarchy within the balanced English constitution.
This essay reassesses Shakespeare’s engagement with Senecan tragedy, arguing both that Hamlet’s use of the Senecan dramatic tradition is more robust and sophisticated than has hitherto been accepted and also that it is best understood as part of a larger cultural conversation about agency and action in revenge tragedy. The essay therefore offers a revisionary account of the reception of Senecan tragedy in early modern England. In doing so, it also suggests that recovering Shakespeare’s engagement with Seneca may require rethinking Hamlet’s own reception history, since Shakespeare’s play is so often discussed as a key text of emergent modernity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.